Filing Flows › Vaxart (VXRT) › Free cash flow
Vaxart (VXRT) free cash flow by quarter
Vaxart's free cash flow was $1.1M in Q3 2026 (third quarter 2026), -61% from Q2 2026. Over the last 4 quarters it ranged from $1.1M (Q3 2026) to $30.7M (Q4 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.1M | -61% | -57% |
| Q2 2026 | $2.7M | -91% | — |
| Q4 2025 | $30.7M | 12× | — |
| Q3 2025 | $2.5M | — | — |
Q3 2026 at a glance
Vaxart, Q3 2026: revenue $10.6M (-85% year over year), operating margin -162.7%, net loss $17.7M, operating cash flow $1.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Vaxart's free cash flow?
Vaxart's free cash flow was $1.1M in Q3 2026 (third quarter 2026), -61% from Q2 2026.
How has Vaxart's free cash flow changed?
Over the last 4 quarters it ranged from $1.1M (Q3 2026) to $30.7M (Q4 2025).